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To investigate the effects of histone methyltransferase ESET (also known as SETDB1) on bone metab-
olism, we analyzed osteoblasts and osteoclasts in ESET knockout animals, and performed osteogen-
esis assays using ESET-null mesenchymal stem cells. We found that ESET deletion severely impairs
osteoblast differentiation but has no effect on osteoclastogenesis, that co-transfection of ESET
represses Runx2-mediated luciferase reporter while siRNA knockdown of ESET activates the lucifer-
ase reporter in mesenchymal cells, and that ESET is required for postnatal expression of Indian
hedgehog protein in the growth plate. As the bone phenotype in ESET-null mice is 100% penetrant,
these results support ESET as a critical regulator of osteoblast differentiation during bone
development.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
The evolutionarily conserved SET (suppressor of variegation,
enhancer of zest and trithorax) domain is present in a group of pro-
teins that function as histone methyltransferases [1]. Among these
histone methyltransferases, the ESET (an ERG-associated protein
with a SET domain, also known as SETDB1 protein) was found to
methylate histone H3 speciﬁcally at lysine 9 (H3-K9) [2]. It has
been reported that the ESET gene is widely expressed in a variety
of cells and tissues, suggesting that the ESET protein may have
multiple cellular functions [3].
The ESET protein contains two major functional domains: the
N-terminal tudor domain is responsible for interaction with other
chromatin modiﬁcation enzymes, while the C-terminal SET domain
catalyzes methylation of H3-K9. Ubiquitous deletion of the ESET
gene was found to cause peri-implantation lethality during
embryogenesis [4], however, it was recently shown possible to
generate viable animals with tissue-speciﬁc deletion of the SET do-
main encoded by exons 15–22 of the ESET gene [5,6].To investigate the effects of histone methyltransferases on the
differentiation of mesenchymal stem cells into osteoblasts and
postnatal bone development, we analyzed the bone phenotype in
mice harboring mesenchymal-speciﬁc deletion of the SET domain
from the ESET protein (therefore inactivates its H3-K9 methyl-
transferase activity). Our results demonstrate that speciﬁc knock-
out of ESET in mesenchymal cells severely impairs osteoblast
differentiation in mutant mice, and is associated with deregulation
of Runx2 and Indian hedgehog (Ihh) that are well known for their
critical roles in the differentiation of mesenchymal stem cells into
both chondrocytes and osteoblasts.
2. Materials and methods
2.1. Generation of mesenchymal-speciﬁc ESET knockout, staining for
osteoblasts and osteoclasts in bone sections
All experiments were reviewed and approved by the Institu-
tional Animal Care and Use Committee at the VA Puget Sound
Health Care System. Generation of the (exon 15&16)Flox/Flox;
Prx1-Cre mutants was described previously [5]. To identify alkaline
phosphatase (ALP)-positive osteoblasts in bone sections, we fol-
lowed a previously published protocol using an ALP staining kit
(Sigma cat #86R-1KT) [7].
Fig. 1. Signiﬁcant decrease of osteoblast activity in ESET-deﬁcient mice. (a)
Proximal tibias from wild-type and (exon 15&16)CKO/CKO littermate were stained
for APL-positive osteoblasts (red) at one week (top panel) and one month (bottom
panel) after birth. Note that in addition to decrease in ALP-positive osteoblasts,
ESET-deﬁcient tibia also lacked the epiphyseal plate. (b) Paraformaldehyde-ﬁxed
and decalciﬁed sections of femoral condyles from one month-old mice were stained
by H&E to show general cell morphology, and by anti-osteocalcin (red) to show
differences in mature osteoblast activity. Scale bar: 400 lm.
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trate-resistant acid phosphatase (TRAP). To visualize osteoclasts
in bone sections, ﬁxed tissue sections were stained using a TRAP
staining kit (Sigma cat #386A-1KT) following the manufacturer’s
instructions. Areas with the most osteoclasts were counted in mul-
tiple light ﬁelds and shown as the average number ± S.D. per light
ﬁeld.
2.2. Osteogenic differentiation of mesenchymal stem cells in vitro
Mesenchymal stem cells were isolated from mouse bone mar-
row as previously described [8]. Cells were then plated in ﬁbronec-
tin/collagen coated 48-well plates at a density of 40  103 cells/
well. After reaching conﬂuence, cells were switched to osteogenic
differentiation medium (DMEM with 15% FBS, 0.1 lM dexametha-
sone, 10 mM b-glycerophosphate, and 0.05 mM L-ascorbic acid-2-
phosphate). Differentiation medium was changed twice a week.
Staining for ALP was done 2 weeks later, and Alizarin red staining
for mineralized matrix was carried out after 3 weeks of culture in
osteogenic medium.
2.3. Inducible siRNA knockdown of ESET expression in ATDC5 cells
Doxycycline induced siRNA knockdown of ESET was achieved
using the pSLIK (single lentiviral vector for inducible knockdown)
platform [9]. Oligonucleotides 50-AGCGACCCGAGGCTTTGCTCT-
TAAATTAGTGAAGCCACAGATGTAATTTAAGAGCAAAGCCTCGGGC-30
and 50-GGCAGCCCGAGGCTTTGCTCTTAAATTACATCTGTGGCTTCAC-
TAATTTAAGAGCAAAGCCTCGGGT-30 were annealed for insertion
into the lentiviral vector to generate a hybrid transcript that fuses
green ﬂuorescence protein (GFP) with a microRNA-like short hair-
pin against nucleotide 3639–3660 of mouse ESET mRNA. A control
microRNA-like short hairpin that does not affect ESET expression
was similarly generated through annealing of 50-AGCGAGTT-
GATCGGCTGTTTGATGATTAGTGAAGCCACAGATGTAATCATCAAA-
CAGCCGATCAACC-30 and 50-
GGCAGGTGGATCGGCTGTTTGATGATTACATCTGTGGCTTCACTAAT-
CATCAAACAGCCGATCAACT-30 and subsequent cloning. After co-
transfection into 293FT cells with the ViraPower lentiviral packag-
ing DNA mix (Invitrogen), supernatants containing the lentivirus
were used to infect ATDC5 cells. Hygromycin (150 lg/ml)-resistant
colonies were expanded, treated in maintenance medium plus or
minus doxycycline (1 lg/ml), checked for GFP induction in live
cells, and lysed at different days post-doxycycline to conﬁrm ESET
knockdown.
2.4. Transfection and luciferase assays
Using the FUGENE 6 reagent, 500 ng of pOG2-Luc [10], 1000 ng
of pCMV-HA-Runx2 and 1000 ng of pSG5-FL-ESET plus 50 ng of
pRL-SV40 were transfected into 5  105 of C3H10T1/2 cells in
one well of a 6-well plate. Similarly, 2500 ng of pOG2-Luc plus
50 ng of pRL-SV40 was transfected into 5  105 ATDC5 cells. After
48 h, the cells were washed once with PBS and lysed with 0.5 ml
passive lysis buffer for measurement of luciferase activity using
the Dual-Luciferase Reporter Assay System (Promega). Fireﬂy lucif-
erase reporter activities were normalized according to the Renilla
luciferase controls. At least three independent transfections were
performed to rule out experimental variations. A separate set of
the transfection was collected in 0.1 ml lysis buffer per well for
western blotting with a rabbit polyclonal anti-ESET (Santa Cruz
Biotch, cat #SC-66884), a rabbit polyclonal anti-Runx2 (Santa Cruz
Biotech, cat #SC-10758), or with HRP-conjugated mouse monoclo-
nal anti-Flag (clone M2) and rat monoclonal anti-HA (clone 3F10).2.5. Immunohistostaining
Paraformaldehyde ﬁxing of tissue sections and antigen retrieval
were described previously [5]. A rabbit polyclonal antibody against
osteocalcin from Abcam (catlog #ab93876) was used at 1:200 dilu-
tion, a rabbit polyclonal antibody against Ihh (Cat #SC-13088, San-
ta Cruz biotechnology) was used at 1:50 dilution. After overnight
incubation with the primary antibody and washes in PBS, the sec-
tions were incubated with a Cy3-conjugated goat anti-rabbit IgG
from Jackson ImmunoResearch Laboratories at a 1:200 dilution
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der a ﬂuorescence microscope.
2.6. Statistics analysis
Differences between two groups were compared using Student
t-test. A P value <0.05 was considered statistically signiﬁcant.
3. Results
3.1. ESET knockout impairs osteoblasts in the long bones
We recently generated ESET(exons 15&16)Flox/Flox; Prx1-Cre
mice, referred to as (exon 15&16)CKO/CKO mutants, with deletion
of the entire bifurcated SET domain from ESET protein in mesen-
chymal cells. When analyzed by micro-computed tomographyFig. 2. Effects of mesenchymal-speciﬁc knockout of ESET on osteoclasts. (a) TRAP-posi
mutants were counted and shown as the average number ± S.D. Asterisks indicate sig
⁄⁄P = 0.61 for 1 month-old). (b) Representative osteoblasts (purple) from one month-old
within the osteoclasts are detected by DAPI and merged with the TRAP-staining images(lCT), these mutant mice exhibited a signiﬁcant decrease of tra-
becular bone when compared with its wild-type littermates [5].
To investigate whether osteoblasts are affected by ESET knockout,
we stained proximal tibia sections of mice for alkaline phosphatase
(ALP)-positive osteoblasts at day 7 and one month after birth. As
shown for day 7 mice in Fig. 1a (top panel), though the staining
intensity of ALP-positive osteoblasts in the knockout long bone
was similar to that of wild-type long bone, the zone of ALP-positive
osteoblasts has advanced signiﬁcantly closer to the articular joint
and is much narrower in depth than that observed in the wild-type
littermate. Primary spongiosa, a landmark bone structure repre-
senting the initial trabecular network, is impaired in (exon
15&16)CKO/CKO mice at postnatal day 7.
When long bone sections from one month-old animals were
stained, a larger decrease in ALP-positive osteoblasts was observed
in ESET knockout mice when compared to wild-type animals. Astive osteoclasts in the proximal tibias of wild-type (WT) and (exon 15&16)CKO/CKO
niﬁcance of the counts in knockout vs WT animals (⁄P = 0.58 for 1 week-old and
proximal tibias of wild-type and (exon 15&16)CKO/CKO mutants are shown. Nuclei
. Genotypes are indicated on the side. Scale bar: 50 lm.
Fig. 3. Impaired osteogenic potential in ESET-deﬁcient mesenchymal stem cells. (a)
Mesenchymal stem cells isolated from the bone barrow of one month-old wild-type
and (exon 15&16)CKO/CKO littermate were cultured in osteogenic medium for
2 weeks, then stained for alkaline phosphatase activity (red). (b) Mesenchymal
stem cells from one month-old wild-type and (exon 15&16)CKO/CKO littermate were
cultured in osteogenic medium for 3 weeks, then stained with alizarin red for
detection of calcium deposit (red). Representative areas in the wells are enlarged for
more details in the corresponding lower panels. Scale bar: 400 lm.
3964 K.A. Lawson et al. / FEBS Letters 587 (2013) 3961–3967shown in Fig. 1a (bottom panel), the decrease of ALP staining in
(exon 15&16)CKO/CKO animals was so drastic that very few regions
could be considered positive for ALP activity. Furthermore, a
marked absence of epiphyseal plates was evident in the knockout
mice when compared to the wild-type animals.
ALP activity is normally detected at an early stage of osteoblast
differentiation and continues to increase during osteoblast matura-
tion until the mineralization phase [11]. It is osteocalcin expres-
sion, not ALP activity, that is generally recognized as a speciﬁc
marker for mature osteoblasts. Since proximal tibias in the knock-
out mice were already found to have severe defects in ALP-positive
osteoblasts, we also analyzed sections of distal femurs from one
month-old wild-type and (exon 15&16)CKO/CKO animals for osteo-
calcin protein in the bone matrix. As shown in Fig. 1b, H&E staining
revealed a much less compact architecture of trabecular bone at
the mutant femoral condyle, and immunohistostaining also
showed a signiﬁcantly lower level of osteocalcin expression within
the mutant bone matrix. It should be pointed out that similar re-
sults were obtained from more than 5 pairs of sex and age-
matched wild-type and (exon 15&16)CKO/CKO mutants, indicating
that the bone phenotype in ESET knockouts is 100% penetrant.
Thus, ESET knockout appears to impair both ALP-positive osteo-
blasts and osteocalcin-positive mature osteoblasts in vivo.
3.2. ESET knockout does not affect osteoclast formation in the long
bones
Defective formation of trabecular bone in (exon 15&16)CKO/CKO
mutant mice may also be caused by an increase in osteoclast activ-
ity leading to acceleration of bone resorption. To investigate
whether osteoclastogenesis was affected by the speciﬁc knockout
of ESET in mesenchymal cells, we stained bone sections for tar-
trate-resistant acid phosphatase (TRAP), a speciﬁc marker of osteo-
clast activity. As shown in Fig. 2a, osteoclast numbers in the tibia
decreased from postnatal day 7 to one month after birth. When
compared to wild-type animals at the same age, there was no sig-
niﬁcant change in the number of TRAP-positive osteoclasts for
ESET-null mutants. In addition, we did not observe a signiﬁcant
change in cell size for multi-nucleated osteoclasts in (exon
15&16)CKO/CKO animals (Fig. 2b). These ﬁndings therefore suggest
that trabecular bone defects found in (exon 15&16)CKO/CKO mice
are not caused by an upregulation of osteoclast activity (through
an increase in osteoclast number or its cell size) following mesen-
chymal-speciﬁc knockout of ESET histone methyltransferase.
3.3. ESET knockout inhibits differentiation of mesenchymal stem cells
into osteoblasts
To validate the above ﬁnding that ESET histone methyltransfer-
ase is critical for osteoblast activity in adult animals, we examined
mesenchymal stem cells from the bone marrow of one month-old
wild-type and (exon 15&16)CKO/CKO mice. To test the differentiation
potential of these mesenchymal stem cells into osteoblasts, we ex-
panded these cells in vitro to near 100% conﬂuency, switched to
osteogenic medium for 2 weeks, then stained for ALP-positive oste-
oblasts. As shown in Fig. 3a, mesenchymal stem cells from wild-
type mice readily differentiated into ALP-positive osteoblasts in
osteogenic medium, whereas only a few ESET-deﬁcient mesenchy-
mal stem cells became ALP-positive osteoblasts under identical
culture conditions. To examine whether these ALP-positive osteo-
blasts could eventually deposit minerals, these cells were cultured
in osteogenic medium for an additional week, then stained with
alizarin red to detect calcium deposition in the extracellular ma-
trix. As shown in Fig. 3b, wild-type osteoblasts indeed formed dis-
tinct foci of calcium deposits, whereas ESET-deﬁcient osteoblasts
failed to do so.3.4. ESET represses Runx2-mediated gene transactivation
We have provided both in vivo and in vitro evidence that
ESET is critical to the differentiation of osteoblasts in the long
bones. As a histone methyltransferase, ESET is known to interact
with transcription factors such as Runx2 [5,12]. Even though
Runx2 is required for osteoblast differentiation during embry-
onic development, transgenic over-expression of Runx2 in oste-
oblasts inhibits osteoblast maturation and causes osteopenia and
spontaneous fractures [11,13]. Since a proper level of Runx2
protein is critical to postnatal bone development, we reasoned
that a subset of the ESET protein may normally bind to and in-
hibit Runx2 activity. Deletion of ESET therefore eliminates such
an inhibition and may cause an oversupply of Runx2 and an
Fig. 4. Repression of Runx2-mediated reporter gene activation by ESET. (a) Diagram of the mOG2-Luc reporter used in transfection of C3H10T1/2 cells is shown at the top.
Total amount of DNA in each transfection was kept constant by the addition of empty vector DNA, and asterisks indicate signiﬁcance of luciferase reporter activities between
plasmid combinations (⁄P = 0.004; ⁄⁄P < 0.001; ⁄⁄⁄P = 0.003). (b) Diagram of the doxycycline (Dox)-inducible siRNA construct is shown on the top. Time-dependent siRNA
knockdown of ESET was assessed by western blotting with an anti-ESET antibody. (c) ATDC5 cells harboring Dox-inducible control siRNA vector (columns 1–2) or Dox-
inducible speciﬁc siRNA vector (columns 3–4) were transfected with the Runx2-responsive mOG2-Luc reporter. Note that cells in columns 2 and 4 were already cultured in
Dox medium for at least 7 days prior to transfection, and kept in Dox medium after transfection. Asterisks indicate signiﬁcance of luciferase reporter activities between cells
cultured in medium with or without Dox (⁄P = 0.65; ⁄⁄P < 0.01).
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To test such a possibility, we transfected mouse mesenchymal
cell line C3H10T1/2 with the pOG2-Luc reporter containing three
copies of Runx2 binding site within the murine osteocalcin gene
2 (mOG2) [10]. Since C3H10T1/2 cells normally do not express
Runx2, co-transfection with Runx2 plasmid activated the pOG2-
Luc reporter by more than 7-fold in the luciferase assay (Fig. 4a).
When Runx2 and ESET plasmids were co-transfected into these
C3H10T1/2 cells, Runx2 activation of mOG2-Luc reporter was sig-
niﬁcantly repressed. To investigate whether this repression of
Runx2 activity by ESET is mediated through its intrinsic histone
methyltransferase activity, we co-transfected Runx2 with the
ESET(C1243T) mutant that replaces the highly conserved cysteine
at 1243 with threonine within the SET domain to inactivate its his-
tone methyltransferase activity [2]. We found that the
ESET(C1243T) mutant is less efﬁcient in repressing Runx2-medi-
ated transactivation of the reporter gene.
To further investigate the ESET-Runx2 interaction, we con-
structed a lentiviral vector to infect the mouse mesenchymal pro-
genitor cell line ATDC5 for doxycycline-inducible ESET knockdown
by siRNA (Fig. 4b). Unlike C3H10T1/2 cells used above, these
ATDC5 cells do express the Runx2 gene and therefore can be used
as a platform to investigate the effects of ESET depletion on endog-
enous Runx2 protein. After transfection with mOG2-Luc reporter
that is sensitive to Runx2 protein, luciferase activity did not change
in ATDC5 cells that harbor the control siRNA construct regardless
of doxycycline treatment (Fig. 4c, top panel, compare columns 1
and 2). In similarly transfected ATDC5 cells that harbor a speciﬁcsiRNA construct against ESET, however, doxycycline treatment re-
sulted in a 2.5-fold increase in luciferase activity (Fig. 4c, top panel,
compare columns 3 and 4). As doxycycline-induced siRNA knock-
down of ESET did not affect Runx2 protein levels in these transfec-
ted cells (Fig. 4c, bottom panels, compare lanes 3 and 4), an
increase in luciferase reporter activity likely reﬂects a scenario in
which ESET normally associates with Runx2 to repress its transac-
tivation activity. These new ﬁndings, together with our previously
published results [5], suggest that when ESET histone methyltrans-
ferase activity is absent in mesenchymal cells (either through gene
knockout or through siRNA knockdown), Runx2-mediated gene
activation becomes more efﬁcient and detrimental to osteoblastic
differentiation.
3.5. ESET knockout disrupts Ihh expression in postnatal growth plates
The severe impairment of osteoblast differentiation in (exon
15&16)CKO/CKO mice also suggested an effect of ESET knockout on
other key regulators of osteogenesis. We noticed that mesenchy-
mal deletion of ESET and chondrocyte-speciﬁc knockout of Ihh in
postnatal mice share many similar skeletal defects [14]. These in-
clude ectopic hypertrophy of chondrocytes in the growth plate,
premature fusion of epiphyseal plates in various endochondral
bones, and defective trabecular bone formation. To investigate
whether mesenchymal deletion of ESET inﬂuences expression of
the Ihh gene in postnatal growth plates, we carried out immuno-
histostaining of proximal tibia from 7 day-old mice with a rabbit
polyclonal anti-Ihh antibody. As shown in Fig. 5 (top panel), a high
level of Ihh expression was indeed detected in hypertrophic chon-
Fig. 5. Disruption of Ihh expression in the growth plate by ESET knockout. Sections of proximal tibia from 7 day-old mice were stained by H&E to show cell morphology, by an
anti-Ihh antibody to show the presence of Ihh protein in hypertrophic chondrocytes. Co-staining with DAPI was used to show distribution of nuclei within the growth plate.
Expected regions of Ihh expression are marked by dotted lines. Genotypes are indicated on the side. Scale bar: 100 lm.
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comparable tibia region in the mutant (exon 15&16)CKO/CKO litter-
mate, however, Ihh expression was severely repressed and Ihh pro-
tein was almost undetectable (Fig. 5, bottom panel).
4. Discussion
In this study we have provided both in vivo and in vitro evi-
dence that osteoblastic differentiation and trabecular bone forma-
tion requires a functional ESET protein, a histone enzyme that
methylates H3-K9. In eukaryotic cells, an evolutionarily conserved
SET domain in a protein implicates its histone methyltransferase
activity, and a group of SET domain-containing proteins (Suv39h,
G9a, GLP and ESET) are responsible for speciﬁc methylation of
H3-K9 [1]. Even though Suv39h, G9a and GLP are ubiquitously ex-
pressed and methylate the same H3-K9 residue as ESET, their
knockout studies have not revealed signiﬁcant changes in bone
phenotype [15]. In contrast, our current study shows that ESET
protein is speciﬁcally required for differentiation of mesenchymal
cells into osteoblasts.
The critical role of ESET in bone formation and maintenance ap-
pears to be related to its unique protein–protein interaction proﬁle.
ESET was originally cloned as a protein that associates with the
transcription factor ERG [2]. In subsequent studies, ESET has been
reported to associate with other transcription factors/chromatin
modiﬁcation enzymes such as Runx2 and HDAC1/2 [5,12]. As we
showed here, ESET likely functions as a repressor of Runx2-medi-
ated gene transactivation, and mutant ESET without its intrinsic
methyltransferase activity is less efﬁcient in such repression. Thus,
the physical and functional interaction between ESET and Runx2 is
of special signiﬁcance to bone formation.
Runx2 is known as a transcription factor indispensable for
osteoblast differentiation during skeletal development in em-
bryos [16]. In postnatal development, however, transgenic
over-expression of Runx2 in cells of the osteoblastic lineage
leads to defective osteoblast maturation and osteopenia
[11,13]. Therefore, a proper level of Runx2 protein is criticalto normal bone formation and maintenance. In light of these
ﬁndings, we speculate that the transactivating ability of Runx2
is tightly regulated by ESET histone methyltransferase and by
its associated histone enzymes. In ESET-deﬁcient mesenchymal
cells, Runx2 is no longer under such a precise control, which
leads to over-expression of genes that impairs osteoblastic dif-
ferentiation of mesenchymal cells.
Through in vitro osteogenesis assays using mesenchymal
stem cells isolated from the bone marrow, we clearly demon-
strated that ESET knockout impairs the ability of mesenchymal
stem cells to differentiate into osteoblasts. This osteogenic de-
fect is most likely a direct result of ESET deﬁciency in mesen-
chymal stem cells, and is in agreement with a previous report
showing that siRNA knockdown of ESET inhibits osteogenic dif-
ferentiation in the pluripotent mesenchymal line ST2 [17]. How-
ever, we cannot rule out the possibility that mesenchymal stem
cells in (exon 15&16)CKO/CKO mice may, as a result of ectopic
chondrocyte hypertrophy and altered matrix composition, fail
to differentiate into osteoblasts due to permanent reprogram-
ming in a microenvironment that is non-conducive to
osteogenesis.
Acknowledgements
We thank Dr. Y. Shinkai for frozen mouse embryos harboring
(exon 15 & 16)-ﬂoxed ESET allele, Dr. J.J. Westendorf for pOG2-
Luc, Dr. G. Karsenty for pCMV-HA-Runx2 plasmid, S.L. Carey for
assistance in mouse breeding, and Dr. Roberto Nicosia’s lab for
assistance in image acquisition. This work is supported in part by
NIH grant RO1 AR051455 (to L.Y.), and by a VAMerit Review Award
from the U.S. Department of Veterans Affairs, Ofﬁce of Research and
Development Biomedical Laboratory Research Program (to H.A.C.).
References
[1] Kouzarides, T. (2007) SnapShot: histone-modifying enzymes. Cell 131, 822.
[2] Yang, L., Xia, L., Wu, D.Y., Wang, H., Chansky, H.A., Schubach, W.H., Hickstein,
D.D. and Zhang, Y. (2002) Molecular cloning of ESET, a novel histone H3-
K.A. Lawson et al. / FEBS Letters 587 (2013) 3961–3967 3967speciﬁc methyltransferase that interacts with ERG transcription factor.
Oncogene 21, 148–152.
[3] Blackburn, M.L., Chansky, H.A., Zielinska-Kwiatkowska, A., Matsui, Y. and Yang,
L. (2003) Genomic structure and expression of the mouse ESET gene encoding
an ERG-associated histone methyltransferase with a SET domain. Biochim.
Biophys. Acta 1629, 8–14.
[4] Dodge, J.E., Kang, Y.K., Beppu, H., Lei, H. and Li, E. (2004) Histone H3-K9
methyltransferase ESET is essential for early development. Mol. Cell. Biol. 24,
2478–2486.
[5] Yang, L., Lawson, K.A., Teteak, C.J., Zou, J., Hacquebord, J., Patterson, D.P.,
Ghatan, A.C., Mei, Q., Zielinska-Kiatkowska, A., Bain, S.D., Fernandes, R.J. and
Chansky, H.A. (2013) ESET histone methyltransferase is essential to
hypertrophic differentiation of growth plate chondrocytes and formation of
epiphyseal plates. Dev. Biol. 380, 99–110.
[6] Tan, S.L., Nishi, M., Ohtsuka, T., Matsui, T., Takemoto, K., Kamio-Miura, A.,
Aburatani, H., Shinkai, Y. and Kageyama, R. (2012) Essential roles of the
histone methyltransferase ESET in the epigenetic control of neural progenitor
cells during development. Development 139, 3806–3816.
[7] Miao, D. and Scutt, A. (2002) Histochemical localization of alkaline
phosphatase activity in decalciﬁed bone and cartilage. J. Histochem.
Cytochem. 50, 333–340.
[8] Soleimani, M. and Nadri, S. (2009) A protocol for isolation and culture of
mesenchymal stem cells from mouse bone marrow. Nat. Protoc. 4, 102–106.
[9] Shin, K.J., Wall, E.A., Zavzavadjian, J.R., Santat, L.A., Liu, J., Hwang, J.I., Rebres, R.,
Roach, T., Seaman, W., Simon, M.I. and Fraser, I.D. (2006) A single lentiviral
vector platform for microRNA-based conditional RNA interference and
coordinated transgene expression. Proc. Natl. Acad. Sci. USA 103, 13759–
13764.
[10] Schroeder, T.M., Kahler, R.A., Li, X. and Westendorf, J.J. (2004) Histone
deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and
regulate osteoblast differentiation. J. Biol. Chem. 279, 41998–42007.[11] Liu, W., Toyosawa, S., Furuichi, T., Kanatani, N., Yoshida, C., Liu, Y., Himeno, M.,
Narai, S., Yamaguchi, A. and Komori, T. (2001) Overexpression of Cbfa1 in
osteoblasts inhibits osteoblast maturation and causes osteopenia with
multiple fractures. J. Cell Biol. 155, 157–166.
[12] Yang, L., Mei, Q., Zielinska-Kwiatkowska, A., Matsui, Y., Blackburn, M.L.,
Benedetti, D., Krumm, A.A., Taborsky Jr., G.J. and Chansky, H.A. (2003) An ERG
(ets-related gene)-associated histone methyltransferase interacts with histone
deacetylases 1/2 and transcription co-repressors mSin3A/B. Biochem. J. 369,
651–657.
[13] Geoffroy, V., Kneissel, M., Fournier, B., Boyde, A. and Matthias, P. (2002) High
bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in
cells of the osteoblastic lineage. Mol. Cell. Biol. 22, 6222–6233.
[14] Maeda, Y., Nakamura, E., Nguyen, M.T., Suva, L.J., Swain, F.L., Razzaque, M.S.,
Mackem, S. and Lanske, B. (2007) Indian Hedgehog produced by postnatal
chondrocytes is essential for maintaining a growth plate and trabecular bone.
Proc. Natl. Acad. Sci. USA 104, 6382–6387.
[15] Tachibana, M., Ueda, J., Fukuda, M., Takeda, N., Ohta, T., Iwanari, H., Sakihama,
T., Kodama, T., Hamakubo, T. and Shinkai, Y. (2005) Histone
methyltransferases G9a and GLP form heteromeric complexes and are both
crucial for methylation of euchromatin at H3-K9. Genes Dev. 19, 815–826.
[16] Jensen, E.D., Schroeder, T.M., Bailey, J., Gopalakrishnan, R. and Westendorf, J.J.
(2008) Histone deacetylase 7 associates with Runx2 and represses its activity
during osteoblast maturation in a deacetylation-independent manner. J. Bone
Miner. Res. 23, 361–372.
[17] Takada, I., Mihara, M., Suzawa, M., Ohtake, F., Kobayashi, S., Igarashi, M., Youn,
M.Y., Takeyama, K., Nakamura, T., Mezaki, Y., Takezawa, S., Yogiashi, Y.,
Kitagawa, H., Yamada, G., Takada, S., Minami, Y., Shibuya, H., Matsumoto, K.
and Kato, S. (2007) A histone lysine methyltransferase activated by non-
canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat. Cell
Biol. 9, 1273–1285.
